3D 1H MRSI of brain tumors at 3.0 tesla using an eight‐channel phased‐array head coil

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Magnetic Resonance Imaging

• Publication date

  2007-07-01

• Fields of study

  Medicine, Physics, Engineering

• Identifiers
  DOI 10.1002/jmri.20970PMID 17659562
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Considerations in applying 3D PRESS H-1 brain MRSI with an eight-channel phased-array coil at 3 T.

  2006cited by this paper
• Spectroscopic imaging of the brain with phased-array coils at 3.0 T.

  2006cited by this paper
• T1rho Dispersion profile of rat tissues in vitro at very low locking fields.

  2006cited by this paper
• Assessment of malignancy in gliomas by 3T 1H MR spectroscopy .

  2005cited by this paper
• Relationship of MR-derived lactate, mobile lipids, and relative blood volume for gliomas in vivo.

  2005cited by this paper
• Considerations in applying 3-D PRESS 1-H MRSI for studies of patients with brain tumors at 3T relative to 1.5T

  2005cited by this paper
• Magnetic resonance spectroscopic imaging

  2004cited by this paper
• A comparative study of myo-inositol quantification using LCmodel at 1.5 T and 3.0 T with 3 D 1H proton spectroscopic imaging of the human brain.

  2004cited by this paper
• High‐resolution 3D proton spectroscopic imaging of the human brain at 3 T: SNR issues and application for anatomy‐matched voxel sizes

  2003cited by this paper
• Magnetic Resonance Imaging at 3.0 Tesla: Challenges and Advantages in Clinical Neurological Imaging

  2003cited by this paper
• High-field magnetic resonance techniques for brain research.

  2003cited by this paper
• Magnetic resonance imaging protocols for examination of the neurocranium at 3 T

  2003cited by this paper
• Analysis of the spatial characteristics of metabolic abnormalities in newly diagnosed glioma patients

  2002cited by this paper
• In vivo molecular imaging for planning radiation therapy of gliomas: An application of 1H MRSI

  2002cited by this paper
• Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens.

  2001cited by this paper
• Analysis of volume MRI and MR spectroscopic imaging data for the evaluation of patients with brain tumors

  2001cited by this paper
• Single‐voxel proton MRS of the human brain at 1.5T and 3.0T

  2001cited by this paper
• Multivoxel 3D proton spectroscopy in the brain at 1.5 versus 3.0 T: signal-to-noise ratio and resolution comparison.

  2001cited by this paper
• An automated technique for the quantitative assessment of 3D‐MRSI data from patients with glioma

  2001cited by this paper
• Very selective suppression pulses for clinical MRSI studies of brain and prostate cancer

  2000cited by this paper
• SENSE: Sensitivity encoding for fast MRI

  1999cited by this paper
• Serial evaluation of patients with brain tumors using volume MRI and 3D 1H MRSI

  1999cited by this paper
• Using pattern analysis of in vivo proton MRSI data to improve the diagnosis and surgical management of patients with brain tumors

  1998cited by this paper
• Resolution improvements in in vivo 1H NMR spectra with increased magnetic field strength.

  1998cited by this paper
• Biological and clinical MRS at ultra‐high field

  1997cited by this paper
• Theory and application of array coils in MR spectroscopy

  1997cited by this paper
• Accurate, noninvasive diagnosis of human brain tumors by using proton magnetic resonance spectroscopy

  1996cited by this paper
• Proton spectroscopic imaging of the human brain using phased array detectors

  1995cited by this paper
• Analysis of brain tumors using 1H magnetic resonance spectroscopy.

  1995cited by this paper
• Mapping of brain tumor metabolites with proton MR spectroscopic imaging: clinical relevance.

  1992cited by this paper

• Translating preclinical MRI methods to clinical oncology

  2019cites this paper
• In vivo MR spectroscopy predicts high tumor grade in endometrial cancer

  2018cites this paper
• Combining Functional Studies with Intraoperative MRI in Glioma Surgery.

  2017cites this paper
• Quantification by the fast Padé transform of magnetic resonance spectroscopic data encoded at 1.5 T: implications for brain tumor diagnostics

  2016cites this paper
• Impacts of MR spectroscopic imaging on glioma patient management

  2014cites this paper
• Target definition for malignant gliomas: no difference in radiation treatment volumes between 1.5T and 3T magnetic resonance imaging.

  2014cites this paper
• Strategies for rapid in vivo 1H and hyperpolarized 13C MR spectroscopic imaging.

  2013cites this paper
• Automated prescription of oblique brain 3D magnetic resonance spectroscopic imaging

  2013cites this paper
• On the use of advanced pattern recognition techniques for the analysis of MRS and MRSI data in neuro-oncology

  2012cites this paper
• Assessment of therapeutic response and treatment planning for brain tumors using metabolic and physiological MRI

  2011cites this paper
• Magnetic resonance in the era of molecular imaging of cancer.

  2011cites this paper
• Improved spatial coverage for brain 3D PRESS MRSI by automatic placement of outer‐volume suppression saturation bands

  2011cites this paper
• MR spectroscopic imaging of glutathione in the white and gray matter at 7 T with an application to multiple sclerosis.

  2010cites this paper
• Improved 1.5 T Magnetic Resonance Spectroscopy in the Human Calf with a Spatially Selective Radio Frequency Surface Coil

  2010cites this paper
• [Advances in diagnostic neuroradiology].

  2010cites this paper
• First intraoperative, shared-resource, ultrahigh-field 3-Tesla magnetic resonance imaging system and its application in low-grade glioma resection.

  2010cites this paper
• Post‐processing correction of the endorectal coil reception effects in MR spectroscopic imaging of the prostate

  2010cites this paper
• 3D sensitivity encoded ellipsoidal MR spectroscopic imaging of gliomas at 3T.

  2009cites this paper
• Relative Cerebral Blood Volume Values to Differentiate High-Grade Glioma Recurrence from Posttreatment Radiation Effect: Direct Correlation between Image-Guided Tissue Histopathology and Localized Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging Measurements

  2009cites this paper
• Elliptical magnetic resonance spectroscopic imaging with GRAPPA for imaging brain tumors at 3 T.

  2009cites this paper
• Molecular Imaging Without Radiopharmaceuticals?

  2009cites this paper
• Quantitative proton magnetic resonance spectroscopy detects abnormalities in dorsolateral prefrontal cortex and motor cortex of patients with frontotemporal lobar degeneration

  2009cites this paper
• Design of cosine modulated very selective suppression pulses for MR spectroscopic imaging at 3T

  2009cites this paper
• 1H spectroscopic imaging of human brain at 3 Tesla: Comparison of fast three‐dimensional magnetic resonance spectroscopic imaging techniques

  2009cites this paper
• Current Awareness in NMR in Biomedicine

  2008cites this paper
• Current Awareness in NMR in Biomedicine

  2008cites this paper